Report Detail

Pharma & Healthcare Global Obstetrics and Gynecology Drugs Market Growth (Status and Outlook) 2022-2028

  • RnM4495398
  • |
  • 21 November, 2022
  • |
  • Global
  • |
  • 110 Pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

The global market for Obstetrics and Gynecology Drugs is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

The APAC Obstetrics and Gynecology Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The United States Obstetrics and Gynecology Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The Europe Obstetrics and Gynecology Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

The China Obstetrics and Gynecology Drugs market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.

Global key Obstetrics and Gynecology Drugs players cover Pfizer, Merck, Eli Lilly, Amgen and Roche, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

Report Coverage
This latest report provides a deep insight into the global Obstetrics and Gynecology Drugs market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.

This report aims to provide a comprehensive picture of the global Obstetrics and Gynecology Drugs market, with both quantitative and qualitative data, to help readers understand how the Obstetrics and Gynecology Drugs market scenario changed across the globe during the pandemic and Russia-Ukraine War.

The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.

Market Segmentation:
The study segments the Obstetrics and Gynecology Drugs market and forecasts the market size by Type (Hormonal Therapy and Non-Hormonal Therapy,), by Application (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,), and region (APAC, Americas, Europe, and Middle East & Africa).

Segmentation by type
Hormonal Therapy
Non-Hormonal Therapy

Segmentation by application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Major companies covered
Pfizer
Merck
Eli Lilly
Amgen
Roche
AstraZeneca
Bayer
Abbott
Abbvie
GlaxoSmithKline
Novartis
Lupin
Johnson & Johnson
Ferring
TherapeuticsMD

Chapter Introduction
Chapter 1: Scope of Obstetrics and Gynecology Drugs, Research Methodology, etc.
Chapter 2: Executive Summary, global Obstetrics and Gynecology Drugs market size and CAGR, Obstetrics and Gynecology Drugs market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Obstetrics and Gynecology Drugs revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Obstetrics and Gynecology Drugs revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Obstetrics and Gynecology Drugs market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including Pfizer, Merck, Eli Lilly, Amgen, Roche, AstraZeneca, Bayer, Abbott and Abbvie, etc.
Chapter 14: Research Findings and Conclusion


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Obstetrics and Gynecology Drugs Market Size 2017-2028
    • 2.1.2 Obstetrics and Gynecology Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
  • 2.2 Obstetrics and Gynecology Drugs Segment by Type
    • 2.2.1 Hormonal Therapy
    • 2.2.2 Non-Hormonal Therapy
  • 2.3 Obstetrics and Gynecology Drugs Market Size by Type
    • 2.3.1 Obstetrics and Gynecology Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
    • 2.3.2 Global Obstetrics and Gynecology Drugs Market Size Market Share by Type (2017-2022)
  • 2.4 Obstetrics and Gynecology Drugs Segment by Application
    • 2.4.1 Hospital Pharmacies
    • 2.4.2 Retail Pharmacies
    • 2.4.3 Online Pharmacies
  • 2.5 Obstetrics and Gynecology Drugs Market Size by Application
    • 2.5.1 Obstetrics and Gynecology Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
    • 2.5.2 Global Obstetrics and Gynecology Drugs Market Size Market Share by Application (2017-2022)

3 Obstetrics and Gynecology Drugs Market Size by Player

  • 3.1 Obstetrics and Gynecology Drugs Market Size Market Share by Players
    • 3.1.1 Global Obstetrics and Gynecology Drugs Revenue by Players (2020-2022)
    • 3.1.2 Global Obstetrics and Gynecology Drugs Revenue Market Share by Players (2020-2022)
  • 3.2 Global Obstetrics and Gynecology Drugs Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Obstetrics and Gynecology Drugs by Regions

  • 4.1 Obstetrics and Gynecology Drugs Market Size by Regions (2017-2022)
  • 4.2 Americas Obstetrics and Gynecology Drugs Market Size Growth (2017-2022)
  • 4.3 APAC Obstetrics and Gynecology Drugs Market Size Growth (2017-2022)
  • 4.4 Europe Obstetrics and Gynecology Drugs Market Size Growth (2017-2022)
  • 4.5 Middle East & Africa Obstetrics and Gynecology Drugs Market Size Growth (2017-2022)

5 Americas

  • 5.1 Americas Obstetrics and Gynecology Drugs Market Size by Country (2017-2022)
  • 5.2 Americas Obstetrics and Gynecology Drugs Market Size by Type (2017-2022)
  • 5.3 Americas Obstetrics and Gynecology Drugs Market Size by Application (2017-2022)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Obstetrics and Gynecology Drugs Market Size by Region (2017-2022)
  • 6.2 APAC Obstetrics and Gynecology Drugs Market Size by Type (2017-2022)
  • 6.3 APAC Obstetrics and Gynecology Drugs Market Size by Application (2017-2022)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Obstetrics and Gynecology Drugs by Country (2017-2022)
  • 7.2 Europe Obstetrics and Gynecology Drugs Market Size by Type (2017-2022)
  • 7.3 Europe Obstetrics and Gynecology Drugs Market Size by Application (2017-2022)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Obstetrics and Gynecology Drugs by Region (2017-2022)
  • 8.2 Middle East & Africa Obstetrics and Gynecology Drugs Market Size by Type (2017-2022)
  • 8.3 Middle East & Africa Obstetrics and Gynecology Drugs Market Size by Application (2017-2022)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Obstetrics and Gynecology Drugs Market Forecast

  • 10.1 Global Obstetrics and Gynecology Drugs Forecast by Regions (2023-2028)
    • 10.1.1 Global Obstetrics and Gynecology Drugs Forecast by Regions (2023-2028)
    • 10.1.2 Americas Obstetrics and Gynecology Drugs Forecast
    • 10.1.3 APAC Obstetrics and Gynecology Drugs Forecast
    • 10.1.4 Europe Obstetrics and Gynecology Drugs Forecast
    • 10.1.5 Middle East & Africa Obstetrics and Gynecology Drugs Forecast
  • 10.2 Americas Obstetrics and Gynecology Drugs Forecast by Country (2023-2028)
    • 10.2.1 United States Obstetrics and Gynecology Drugs Market Forecast
    • 10.2.2 Canada Obstetrics and Gynecology Drugs Market Forecast
    • 10.2.3 Mexico Obstetrics and Gynecology Drugs Market Forecast
    • 10.2.4 Brazil Obstetrics and Gynecology Drugs Market Forecast
  • 10.3 APAC Obstetrics and Gynecology Drugs Forecast by Region (2023-2028)
    • 10.3.1 China Obstetrics and Gynecology Drugs Market Forecast
    • 10.3.2 Japan Obstetrics and Gynecology Drugs Market Forecast
    • 10.3.3 Korea Obstetrics and Gynecology Drugs Market Forecast
    • 10.3.4 Southeast Asia Obstetrics and Gynecology Drugs Market Forecast
    • 10.3.5 India Obstetrics and Gynecology Drugs Market Forecast
    • 10.3.6 Australia Obstetrics and Gynecology Drugs Market Forecast
  • 10.4 Europe Obstetrics and Gynecology Drugs Forecast by Country (2023-2028)
    • 10.4.1 Germany Obstetrics and Gynecology Drugs Market Forecast
    • 10.4.2 France Obstetrics and Gynecology Drugs Market Forecast
    • 10.4.3 UK Obstetrics and Gynecology Drugs Market Forecast
    • 10.4.4 Italy Obstetrics and Gynecology Drugs Market Forecast
    • 10.4.5 Russia Obstetrics and Gynecology Drugs Market Forecast
  • 10.5 Middle East & Africa Obstetrics and Gynecology Drugs Forecast by Region (2023-2028)
    • 10.5.1 Egypt Obstetrics and Gynecology Drugs Market Forecast
    • 10.5.2 South Africa Obstetrics and Gynecology Drugs Market Forecast
    • 10.5.3 Israel Obstetrics and Gynecology Drugs Market Forecast
    • 10.5.4 Turkey Obstetrics and Gynecology Drugs Market Forecast
    • 10.5.5 GCC Countries Obstetrics and Gynecology Drugs Market Forecast
  • 10.6 Global Obstetrics and Gynecology Drugs Forecast by Type (2023-2028)
  • 10.7 Global Obstetrics and Gynecology Drugs Forecast by Application (2023-2028)

11 Key Players Analysis

  • 11.1 Pfizer
    • 11.1.1 Pfizer Company Information
    • 11.1.2 Pfizer Obstetrics and Gynecology Drugs Product Offered
    • 11.1.3 Pfizer Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.1.4 Pfizer Main Business Overview
    • 11.1.5 Pfizer Latest Developments
  • 11.2 Merck
    • 11.2.1 Merck Company Information
    • 11.2.2 Merck Obstetrics and Gynecology Drugs Product Offered
    • 11.2.3 Merck Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.2.4 Merck Main Business Overview
    • 11.2.5 Merck Latest Developments
  • 11.3 Eli Lilly
    • 11.3.1 Eli Lilly Company Information
    • 11.3.2 Eli Lilly Obstetrics and Gynecology Drugs Product Offered
    • 11.3.3 Eli Lilly Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.3.4 Eli Lilly Main Business Overview
    • 11.3.5 Eli Lilly Latest Developments
  • 11.4 Amgen
    • 11.4.1 Amgen Company Information
    • 11.4.2 Amgen Obstetrics and Gynecology Drugs Product Offered
    • 11.4.3 Amgen Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.4.4 Amgen Main Business Overview
    • 11.4.5 Amgen Latest Developments
  • 11.5 Roche
    • 11.5.1 Roche Company Information
    • 11.5.2 Roche Obstetrics and Gynecology Drugs Product Offered
    • 11.5.3 Roche Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.5.4 Roche Main Business Overview
    • 11.5.5 Roche Latest Developments
  • 11.6 AstraZeneca
    • 11.6.1 AstraZeneca Company Information
    • 11.6.2 AstraZeneca Obstetrics and Gynecology Drugs Product Offered
    • 11.6.3 AstraZeneca Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.6.4 AstraZeneca Main Business Overview
    • 11.6.5 AstraZeneca Latest Developments
  • 11.7 Bayer
    • 11.7.1 Bayer Company Information
    • 11.7.2 Bayer Obstetrics and Gynecology Drugs Product Offered
    • 11.7.3 Bayer Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.7.4 Bayer Main Business Overview
    • 11.7.5 Bayer Latest Developments
  • 11.8 Abbott
    • 11.8.1 Abbott Company Information
    • 11.8.2 Abbott Obstetrics and Gynecology Drugs Product Offered
    • 11.8.3 Abbott Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.8.4 Abbott Main Business Overview
    • 11.8.5 Abbott Latest Developments
  • 11.9 Abbvie
    • 11.9.1 Abbvie Company Information
    • 11.9.2 Abbvie Obstetrics and Gynecology Drugs Product Offered
    • 11.9.3 Abbvie Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.9.4 Abbvie Main Business Overview
    • 11.9.5 Abbvie Latest Developments
  • 11.10 GlaxoSmithKline
    • 11.10.1 GlaxoSmithKline Company Information
    • 11.10.2 GlaxoSmithKline Obstetrics and Gynecology Drugs Product Offered
    • 11.10.3 GlaxoSmithKline Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.10.4 GlaxoSmithKline Main Business Overview
    • 11.10.5 GlaxoSmithKline Latest Developments
  • 11.11 Novartis
    • 11.11.1 Novartis Company Information
    • 11.11.2 Novartis Obstetrics and Gynecology Drugs Product Offered
    • 11.11.3 Novartis Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.11.4 Novartis Main Business Overview
    • 11.11.5 Novartis Latest Developments
  • 11.12 Lupin
    • 11.12.1 Lupin Company Information
    • 11.12.2 Lupin Obstetrics and Gynecology Drugs Product Offered
    • 11.12.3 Lupin Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.12.4 Lupin Main Business Overview
    • 11.12.5 Lupin Latest Developments
  • 11.13 Johnson & Johnson
    • 11.13.1 Johnson & Johnson Company Information
    • 11.13.2 Johnson & Johnson Obstetrics and Gynecology Drugs Product Offered
    • 11.13.3 Johnson & Johnson Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.13.4 Johnson & Johnson Main Business Overview
    • 11.13.5 Johnson & Johnson Latest Developments
  • 11.14 Ferring
    • 11.14.1 Ferring Company Information
    • 11.14.2 Ferring Obstetrics and Gynecology Drugs Product Offered
    • 11.14.3 Ferring Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.14.4 Ferring Main Business Overview
    • 11.14.5 Ferring Latest Developments
  • 11.15 TherapeuticsMD
    • 11.15.1 TherapeuticsMD Company Information
    • 11.15.2 TherapeuticsMD Obstetrics and Gynecology Drugs Product Offered
    • 11.15.3 TherapeuticsMD Obstetrics and Gynecology Drugs Revenue, Gross Margin and Market Share (2020-2022)
    • 11.15.4 TherapeuticsMD Main Business Overview
    • 11.15.5 TherapeuticsMD Latest Developments

12 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on Obstetrics and Gynecology Drugs. Industry analysis & Market Report on Obstetrics and Gynecology Drugs is a syndicated market report, published as Global Obstetrics and Gynecology Drugs Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Obstetrics and Gynecology Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,997.54
5,995.08
3,484.32
6,968.64
498,455.40
996,910.80
298,948.80
597,897.60
Credit card Logo

Related Reports


Reason to Buy

Request for Sample of this report